CYTK
Cytokinetics Inc
67.60$
-1.8%
vs. previous close
Closing price · As of: Sep 21, 2026
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | -38.9% | +271.3% | -87.4% | +135.6% | -14.7% | +107.8% | +26.2% | +34.3% | -92.0% | +145.3% | +376.6% | |
| – | +4.4% | +29.1% | +50.8% | -1.3% | -3.4% | +12.6% | +65.0% | +50.6% | +37.1% | +2.8% | -97.0% | |
| – | -805.6% | – | -265.4% | – | – | – | – | – | – | – | – | |
| – | +4.4% | +29.1% | +50.8% | -1.3% | -3.4% | +12.6% | +65.0% | +50.6% | +37.1% | +2.8% | +19.6% | |
| – | +13.9% | +41.5% | +31.1% | -14.2% | +26.6% | +33.4% | +83.3% | +83.9% | -2.5% | +24.0% | +32.0% | |
| – | +13.9% | +41.5% | +31.1% | -14.2% | +26.6% | +33.4% | +83.3% | +83.9% | -2.5% | +24.0% | +220.5% | |
| – | – | – | -706.8% | – | – | – | – | – | – | – | – | |
| – | -13.0% | +2,276.6% | +660.8% | +26.9% | +26.9% | +41.4% | -24.2% | +74.4% | +12.7% | +50.0% | +20.1% | |
| – | – | – | -876.7% | – | – | – | – | – | – | – | – | |
| – | – | – | – | +514.5% | +552.8% | +34.7% | -26.6% | -49.7% | -13.8% | – | – | |
| – | – | – | -876.7% | – | – | – | – | – | – | – | – | |
| – | – | – | -660.5% | – | – | – | – | – | – | – | – |
Data as of: September 21, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.